Core Business
Excelya stands apart from all other clinical development companies working for healthcare businesses. We are the only independent European CRO providing R&D players with full-service offers within a cooperative framework. Our clients can depend on the highest degree of involvement to guarantee the excellence they need.Our customized solutions perfectly match the scope and specificity of our clients’ research projects.Our approach is centered on understanding our clients’ needs and a capacity for initiative driven by efficiency, in addition to perfect operational, scientific and regulatory precision. We actively cultivate this professional and human mindset within our 800 strong team force. Our team members are trained to invest their work with their best in personality and commitment.They embody our two fundamental values : the ambition of excellence and team enterprising.
Specific Areas of Activity
What do we do?
Excelya covers Europe with a network of local representative affiliates and experts in 24 countries, closest to the finest sites of excellence and local Authorities to be best positioned for meeting deadlines and enrolment milestones. Excelya is a unique CRO providing customized service for its clients offering a consistently superior level of quality level as well as Full-Service Solutions, FSP and Consulting.
For what type of studies?
Excelya expert teams have conducted a large number of Phase I to IV trials for drugs, medical devices or combined drugs and devices as well as Phase IV / NIS non interventional studies/ IS, Real-World Evidence (RWE) studies and Commercial optimization.
Our goal: to deliver on-time, on-budget and on-quality clinical research enhanced by the commitment, passion and innovative mindset of our expert and project teams.
Who are our clients?
Excelya works for Pharmaceutical Companies and Biotechs on some of the most innovative drug candidates (including gene therapy) and disruptive drug delivery technology. We have also been working for MedTech, Big Pharma and Biotechs in their Medical Device development program and In-Vitro Diagnostic Devices.
Key areas of focus
Auditing – Data Management – Early Clinical Phases – eCRF – Information – Investigator Network – Late phase IV – Legal Representation – Medical Advising – Medical Writing – People selection & placement – Pharmacovigilance & Drug – Project Management – Regulatory – Safety – Statistics – Training & coaching – Translation
Legal Representative
Evert Cuppens
Managing Director
ecuppens@excelya.com
+32474760460